{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:58:35Z","timestamp":1785355115609,"version":"3.55.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,7]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Portal hypertension (PHT) results from increased intrahepatic vascular resistance and augmented portal venous blood flow. Although cirrhosis remains the predominant etiology of PHT, non-cirrhotic PHT also requires clinical attention. This article reports a rare case of PHT with portal vein thrombosis and gastroesophageal varices secondary to essential thrombocythemia (ET).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>An 82-year-old female patient was admitted due to \u201chematemesis and melena,\u201d abdominal computed tomography revealed ascites, altered liver morphology, mild splenomegaly and PHT. The patient was admitted with a diagnosis of \u201cdecompensated cirrhosis.\u201d She maintained normal liver function over a 6-month follow-up, subsequently, the condition progressed to portal vein thrombosis, leading to gastrointestinal bleeding. Laboratory assessments at this stage revealed normal levels of albumin, liver enzymes, bilirubin, and coagulation factors, with no ascites formation, inconsistent with decompensated cirrhosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>ET was diagnosed based on Bone Marrow Aspiration and Biopsy, the JAK2 mutation was identified with a variant allele frequency of 42.2%. PHT and thrombosis in this case were attributed to ET.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient was treated with hydroxyurea and ruxolitinib, endoscopic injection cyanoacrylate\/sclerotherapy and endoscopic variceal ligation were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Post-discharge, oral antitumor agents and aspirin for antiplatelet therapy were prescribed, with outpatient follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>ET can also lead to PHT, portal vein thrombosis, and esophageal varices. Clinicians should consider these possibilities when dealing with such patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000045855","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T18:02:33Z","timestamp":1762538553000},"page":"e45855","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Portal hypertension caused by essential thrombocythemia: A case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8368-9564","authenticated-orcid":false,"given":"Yutao","family":"Fang","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Hangzhou Cancer Hospital, Hangzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongya","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260729","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.3748\/wjg.v26.i40.6111","article-title":"Cirrhotic portal hypertension: from pathophysiology to novel therapeutics.","volume":"26","author":"Gunarathne","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R2-20260729","first-page":"87","article-title":"Progress in the clinical diagnosis of idiopathic noncirrhotic portal hypertension.","volume":"29","author":"Zhang","year":"2021","journal-title":"Chin J Hepatol"},{"key":"R3-20260729","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2013.08.013","article-title":"Non-cirrhotic portal hypertension-diagnosis and management.","volume":"60","author":"Khanna","year":"2014","journal-title":"J Hepatol"},{"key":"R4-20260729","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cld.2019.07.007","article-title":"Portal hypertension: pathogenesis and diagnosis.","volume":"23","author":"Turco","year":"2019","journal-title":"Clin Liver Dis"},{"key":"R5-20260729","first-page":"1","article-title":"Non-cirrhotic portal hypertension: the highlight of its diagnosis.","volume":"25","author":"He","year":"2022","journal-title":"J Pract Hepatol"},{"key":"R6-20260729","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2019.01.265","article-title":"Diagnosis, development, and treatment of portal vein thrombosis inpatients with and without cirrhosis.","volume":"156","author":"Intagliata","year":"2019","journal-title":"Gastroenterology"},{"key":"R7-20260729","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41408-018-0054-y","article-title":"The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion.","volume":"8","author":"Barbui","year":"2018","journal-title":"Blood Cancer J"},{"key":"R8-20260729","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.27216","article-title":"Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.","volume":"99","author":"Tefferi","year":"2024","journal-title":"Am J Hematol"},{"key":"R9-20260729","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.12998\/wjcc.v9.i8.1871","article-title":"Gastroesophageal varices in a patient presenting with essential thrombocythemia: a case report.","volume":"9","author":"Wang","year":"2021","journal-title":"World J Clin Cases"},{"key":"R10-20260729","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1172\/JCI90312","article-title":"JAK2-V617F promotes venous thrombosis through \u03b21\/\u03b22 integrin activation.","volume":"128","author":"Edelmann","year":"2018","journal-title":"J Clin Invest"},{"key":"R11-20260729","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3324\/haematol.2018.195321","article-title":"Vascular endothelial cell expression of JAK2V617F is sufficient topromote a pro-thrombotic state due to increased P-selectin expression.","volume":"104","author":"Guy","year":"2019","journal-title":"Haematologica"},{"key":"R12-20260729","first-page":"872","article-title":"Portal hypertension caused by essential thrombocytosis: a case report and literature review.","volume":"19","author":"Li","year":"2020","journal-title":"Chin J Mult Organ Dis Elder"},{"key":"R13-20260729","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1055\/s-0038-1667015","article-title":"Endothelial cells harbouring the JAK2V617F mutation display pro-adherent and pro-thrombotic features.","volume":"118","author":"Guadall","year":"2018","journal-title":"Thromb Haemost"},{"key":"R14-20260729","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1111\/jth.15095","article-title":"Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm.","volume":"18","author":"Castiglione","year":"2020","journal-title":"J Thromb Haemost"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:02:32Z","timestamp":1785351752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":14,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045855","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"2025-06-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}